Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc H Levin

Showing results (31-40 of 46) with videos related to

Pageof 5
Sort By:
Journal of Medicinal Chemistry|January 19, 2017
Nanomolar-Potency Aminophenyl-1,3,5-triazine Activators of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Chloride Channel for Prosecretory Therapy of Dry Eye DiseasesSujin Lee, Puay-Wah Phuan, Christian M Felix, et al.
Survey of Ophthalmology|June 17, 2015
Second chancesLina Nagia, Jennifer I Doyle, James R Hackney, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 5, 2016
Small-molecule CFTR activators increase tear secretion and prevent experimental dry eye diseaseAlyssa M Flores, Scott D Casey, Christian M Felix, et al.
Journal of AAPOS : the Official Publication of the American Association for Pediatric Ophthalmology and Strabismus|June 24, 2023
Anterior segment ischemia following strabismus surgery in a young adult using gender-affirming estrogen hormone therapyAmal Al-Lozi, Euna B Koo, Scott R Lambert, et al.
The Journal of General Physiology|May 22, 2026
Model of ocular surface ion and water transport predicts efficacy of dry eye therapeuticsVarun Verma, Ethan S Lindgren, Marc H Levin, et al.
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|January 15, 2020
Nanomolar Potency Aminophenyltriazine CFTR Activator Reverses Corneal Epithelial Injury in a Mouse Model of Dry EyeXiaolan Chen, Sujin Lee, Tianyi Zhang, et al.
The British Journal of Ophthalmology|August 22, 2015
Risk of optic pathway glioma in children with neurofibromatosis type 1 and optic nerve tortuosity or nerve sheath thickeningMarc H Levin, Gregory T Armstrong, Julian H Broad, et al.
Cellular and Molecular Gastroenterology and Hepatology|April 30, 2016
CFTR activator increases intestinal fluid secretion and normalizes stool output in a mouse model of constipationOnur Cil, Puay-Wah Phuan, Sujin Lee, et al.
World Neurosurgery|February 2, 2013
Orbital congestion complicating treatment of cerebral vascular anomaliesMarc H Levin, Heather E Moss, Stacy L Pineles, et al.
Journal of the Neurological Sciences|November 30, 2010
Asymmetric bilateral demyelinating optic neuropathy from tacrolimus toxicitySriram Venneti, Heather E Moss, Marc H Levin, et al.
Pageof 5

Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
Journal of Medicinal Chemistry|January 19, 2017
Nanomolar-Potency Aminophenyl-1,3,5-triazine Activators of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Chloride Channel for Prosecretory Therapy of Dry Eye DiseasesSujin Lee, Puay-Wah Phuan, Christian M Felix, et al.
Survey of Ophthalmology|June 17, 2015
Second chancesLina Nagia, Jennifer I Doyle, James R Hackney, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 5, 2016
Small-molecule CFTR activators increase tear secretion and prevent experimental dry eye diseaseAlyssa M Flores, Scott D Casey, Christian M Felix, et al.
Journal of AAPOS : the Official Publication of the American Association for Pediatric Ophthalmology and Strabismus|June 24, 2023
Anterior segment ischemia following strabismus surgery in a young adult using gender-affirming estrogen hormone therapyAmal Al-Lozi, Euna B Koo, Scott R Lambert, et al.
The Journal of General Physiology|May 22, 2026
Model of ocular surface ion and water transport predicts efficacy of dry eye therapeuticsVarun Verma, Ethan S Lindgren, Marc H Levin, et al.
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|January 15, 2020
Nanomolar Potency Aminophenyltriazine CFTR Activator Reverses Corneal Epithelial Injury in a Mouse Model of Dry EyeXiaolan Chen, Sujin Lee, Tianyi Zhang, et al.
The British Journal of Ophthalmology|August 22, 2015
Risk of optic pathway glioma in children with neurofibromatosis type 1 and optic nerve tortuosity or nerve sheath thickeningMarc H Levin, Gregory T Armstrong, Julian H Broad, et al.
Cellular and Molecular Gastroenterology and Hepatology|April 30, 2016
CFTR activator increases intestinal fluid secretion and normalizes stool output in a mouse model of constipationOnur Cil, Puay-Wah Phuan, Sujin Lee, et al.
World Neurosurgery|February 2, 2013
Orbital congestion complicating treatment of cerebral vascular anomaliesMarc H Levin, Heather E Moss, Stacy L Pineles, et al.
Journal of the Neurological Sciences|November 30, 2010
Asymmetric bilateral demyelinating optic neuropathy from tacrolimus toxicitySriram Venneti, Heather E Moss, Marc H Levin, et al.
Pageof 5